Pegsunercept

DB06611InvestigationalProtein Based Therapies

Pegsunercept is used for treating rheumatoid arthritis. Phase II clinical trials were completed in January 2010.

Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in rheumatoid arthritis.Curator reviewed
Also known as
sTNF-R1

Resolves to

Compound
UNIIQ5I7SFZ853CAS330988-75-5KEGGD05393
Targets
P01375TNF

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
36Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Pegsunercept, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In